+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Anti-Inflammatory Therapeutics Market 2020-2024 - Product Image

Global Anti-Inflammatory Therapeutics Market 2020-2024

  • ID: 5008905
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • MORE

Global Anti-Inflammatory Therapeutics Market 2020-2024

The publisher has been monitoring the global anti-inflammatory therapeutics market 2020-2024 and it is poised to grow by USD 27.53 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report on the global anti-inflammatory therapeutics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of imid. In addition, emergence of novel anti-inflammatory drugs is anticipated to boost the growth of the global anti-inflammatory therapeutics market as well.

Market Segmentation

This global anti-inflammatory therapeutics market 2020-2024 is segmented as below:

Application:

  • RA
  • Psoriasis
  • MS

Geographic Segmentation:

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global anti-inflammatory therapeutics market 2020-2024 growth

This study identifies emergence of novel anti-inflammatory drugs as the prime reasons driving the global anti-inflammatory therapeutics market 2020-2024 growth during the next few years.

Prominent vendors in global anti-inflammatory therapeutics market 2020-2024

The publisher provides a detailed analysis of around 25 vendors operating in the global anti-inflammatory therapeutics market 2020-2024, including some of the vendors such as AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Customer landscape
  • Overview
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Key Finding 9
9. Market in focus
10. Parent market
11. Market characteristics
12. Product / Service portfolio of key vendors included in the market definition
13. Market segments
14. Global - Market size and forecast 2019 - 2024 ($ billion)
15. Global market: Year-over-year growth 2019 - 2024 (%)
16. Five forces analysis 2019 & 2024
17. Bargaining power of buyers
18. Bargaining power of suppliers
19. Threat of new entrants
20. Threat of substitutes
21. Threat of rivalry
22. Market condition - Five forces 2019
23. RA - Market size and forecast 2019-2024 ($ billion)
24. RA - Year-over-year growth 2019-2024 (%)
25. Psoriasis - Market size and forecast 2019-2024 ($ billion)
26. Psoriasis - Year-over-year growth 2019-2024 (%)
27. MS - Market size and forecast 2019-2024 ($ billion)
28. MS - Year-over-year growth 2019-2024 (%)
29. Anti-inflammatory biologicals - Market size and forecast 2019-2024 ($ billion)
30. Anti-inflammatory biologicals - Year-over-year growth 2019-2024 (%)
31. Corticosteriods - Market size and forecast 2019-2024 ($ billion)
32. Corticosteriods - Year-over-year growth 2019-2024 (%)
33. NSAIDs - Market size and forecast 2019-2024 ($ billion)
34. NSAIDs - Year-over-year growth 2019-2024 (%)
35. Customer landscape
36. Impact of drivers and challenges
37. Vendor landscape
38. Landscape disruption
39. Industry risks
40. Vendors covered
41. Market positioning of vendors
42. AbbVie Inc - Overview
43. AbbVie Inc - Business segments
44. AbbVie Inc - Key offerings
45. AbbVie Inc - Key customers
46. AbbVie Inc - Segment focus
47. Amgen Inc - Overview
48. Amgen Inc - Business segments
49. Amgen Inc - Key offerings
50. Amgen Inc - Key customers
51. Amgen Inc - Segment focus
52. AstraZeneca Plc - Overview
53. AstraZeneca Plc - Business segments
54. AstraZeneca Plc - Key offerings
55. AstraZeneca Plc - Key customers
56. AstraZeneca Plc - Segment focus
57. Bayer AG - Overview
58. Bayer AG - Business segments
59. Bayer AG - Key offerings
60. Bayer AG - Key customers
61. Bayer AG - Segment focus
62. F Hoffmann-La Roche Ltd - Overview
63. F Hoffmann-La Roche Ltd - Business segments
64. F Hoffmann-La Roche Ltd - Key offerings
65. F Hoffmann-La Roche Ltd - Key customers
66. F Hoffmann-La Roche Ltd - Segment focus
67. GlaxoSmithKline Plc - Overview
68. GlaxoSmithKline Plc - Business segments
69. GlaxoSmithKline Plc - Key offerings
70. GlaxoSmithKline Plc - Key customers
71. GlaxoSmithKline Plc - Segment focus
72. Johnson & Johnson - Overview
73. Johnson & Johnson - Business segments
74. Johnson & Johnson - Key offerings
75. Johnson & Johnson - Key customers
76. Johnson & Johnson - Segment focus
77. Merck & Co Inc - Overview
78. Merck & Co Inc - Business segments
79. Merck & Co Inc - Key offerings
80. Merck & Co Inc - Key customers
81. Merck & Co Inc - Segment focus
82. Novartis AG - Overview
83. Novartis AG - Business segments
84. Novartis AG - Key offerings
85. Novartis AG - Key customers
86. Novartis AG - Segment focus
87. Pfizer Inc - Overview
88. Pfizer Inc - Business segments
89. Pfizer Inc - Key offerings
90. Pfizer Inc - Key customers
91. Pfizer Inc - Segment focus
92. Currency conversion rates for US$
93. Research Methodology
94. Validation techniques employed for market sizing
95. Information sources
96. List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • MORE
The publisher recognizes the following companies as the key players in the global anti-inflammatory therapeutics market 2020-2024: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the emergence of novel anti-inflammatory drugs."

According to the report, one of the major drivers for this market is the increase in prevalence of imid.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll